<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Trade Secret vs Patent Protection for Startups</title>
  <description>How do startups decide between trade secret and patent protection? What does the analysis look like? Sandy Chan, Executive Director &amp;amp;amp; General Counsel at IP Counsel Cafe speaks with Kevin Brown, Vice President of IP at Recursion Pharmaceuticals, a clinical-stage biotechnology company that combines experimental biology and automation with artificial intelligence to discover potential drugs; and Stephanie Southwick, Legal Counsel and Investment Manager at Omni Bridgeway, a global leader in dispute resolution finance. </description>
  <author_name>IP Counsel Cafe</author_name>
  <author_url>https://www.ipcounselcafe.com</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/18328391/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/item/18328391</thumbnail_url>
</oembed>
